top of page

Open Psychedelic

Evaluation Nexus


Our Team Members

Chris Stauffer, MD

An expert in Psychiatry and Addiction Medicine at OHSU and the Portland VA, Dr. Stauffer's research centers on psychopharmacology in treating psychiatric disorders, especially in veterans. He leads clinical trials in MDMA and psilocybin therapies.

Jason Luoma, Ph.D.

CEO of Portland Psychotherapy Clinic, Dr. Luoma is a key figure in psychological research, including psychedelics. Known for his work in Acceptance and Commitment Therapy, he contributes significantly to practice-based research.

Adie Rae, PhD

Dr. Rae, a neuroscientist at Legacy Research Institute, focuses on cannabis, pain management, and addiction. She plays a pivotal role in shaping Oregon's cannabis and psychedelic policies.

Todd Korthuis, MD, MPH

Dr. Korthuis, a Professor at OHSU, spearheads the Addiction Medicine Program. His work, blending addiction treatment with HIV care, has made significant impacts in healthcare integration and psilocybin research.

Alissa Bazinet, PhD

A leader in psychedelic-assisted therapy at Sequoia Center, Dr. Bazinet focuses on substance impact on the brain and behavior. Trained in MDMA and ketamine therapies, she's integral in Oregon's psilocybin therapy development and psychedelic harm reduction.

bottom of page